Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries RTO Deadline to Lead in Securities Fraud Lawsuit is January 27, 2025 - Contact Kaplan Fox & Kilsheimer LLP By: TheNewswire.com December 06, 2024 at 13:00 PM EST NEW YORK - (NewMediaWire) - December 06, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Rentokil Initial plc (“Rentokil” or the “Company”) (NYSE: RTO) on behalf of investors that purchased Rentokil American Depositary Shares (“ADS”) between December 1, 2023 and September 10, 2024 (the “Class Period”).CLICK HERE TO JOIN THE CASEIf you are an investor in Rentokil ADSs and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than January 27, 2025 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process.Prior to the Class Period, on October 12, 2022 Rentokil announced the completion of its acquisition of Terminix Global Holdings, Inc. (“Terminix”), making Terminix part of Rentokil’s North America pest control business.According to the complaint, on September 11, 2024, before the markets opened, Rentokil provided an unscheduled “Trading Update,” which announced that the Company now expects only 1% organic revenue growth in North America for the second half of 2024, well below the Company’s prior guidance.On this news, the price of Rentokil ADSs fell $6.65 per share, over 21%, to close at $24.95 per ADS on September 11, 2024.The complaint alleges, among other things, that the Defendants made materially false and misleading statements and failed to disclose to investors that throughout the Class Period Rentokil experienced disruption and significant, ongoing, self-inflicted execution challenges integrating Terminix, which negatively impacted the Company’s business operations, particularly the Company’s organic revenue growth in North America.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.If you have any questions about this Notice, your rights, or your interests, please contact:CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.comLaurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
RTO Deadline to Lead in Securities Fraud Lawsuit is January 27, 2025 - Contact Kaplan Fox & Kilsheimer LLP By: TheNewswire.com December 06, 2024 at 13:00 PM EST NEW YORK - (NewMediaWire) - December 06, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Rentokil Initial plc (“Rentokil” or the “Company”) (NYSE: RTO) on behalf of investors that purchased Rentokil American Depositary Shares (“ADS”) between December 1, 2023 and September 10, 2024 (the “Class Period”).CLICK HERE TO JOIN THE CASEIf you are an investor in Rentokil ADSs and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than January 27, 2025 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process.Prior to the Class Period, on October 12, 2022 Rentokil announced the completion of its acquisition of Terminix Global Holdings, Inc. (“Terminix”), making Terminix part of Rentokil’s North America pest control business.According to the complaint, on September 11, 2024, before the markets opened, Rentokil provided an unscheduled “Trading Update,” which announced that the Company now expects only 1% organic revenue growth in North America for the second half of 2024, well below the Company’s prior guidance.On this news, the price of Rentokil ADSs fell $6.65 per share, over 21%, to close at $24.95 per ADS on September 11, 2024.The complaint alleges, among other things, that the Defendants made materially false and misleading statements and failed to disclose to investors that throughout the Class Period Rentokil experienced disruption and significant, ongoing, self-inflicted execution challenges integrating Terminix, which negatively impacted the Company’s business operations, particularly the Company’s organic revenue growth in North America.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.If you have any questions about this Notice, your rights, or your interests, please contact:CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.comLaurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com
NEW YORK - (NewMediaWire) - December 06, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Rentokil Initial plc (“Rentokil” or the “Company”) (NYSE: RTO) on behalf of investors that purchased Rentokil American Depositary Shares (“ADS”) between December 1, 2023 and September 10, 2024 (the “Class Period”).CLICK HERE TO JOIN THE CASEIf you are an investor in Rentokil ADSs and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than January 27, 2025 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process.Prior to the Class Period, on October 12, 2022 Rentokil announced the completion of its acquisition of Terminix Global Holdings, Inc. (“Terminix”), making Terminix part of Rentokil’s North America pest control business.According to the complaint, on September 11, 2024, before the markets opened, Rentokil provided an unscheduled “Trading Update,” which announced that the Company now expects only 1% organic revenue growth in North America for the second half of 2024, well below the Company’s prior guidance.On this news, the price of Rentokil ADSs fell $6.65 per share, over 21%, to close at $24.95 per ADS on September 11, 2024.The complaint alleges, among other things, that the Defendants made materially false and misleading statements and failed to disclose to investors that throughout the Class Period Rentokil experienced disruption and significant, ongoing, self-inflicted execution challenges integrating Terminix, which negatively impacted the Company’s business operations, particularly the Company’s organic revenue growth in North America.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.If you have any questions about this Notice, your rights, or your interests, please contact:CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.comLaurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com
